Viewing Study NCT00580333


Ignite Creation Date: 2025-12-25 @ 2:48 AM
Ignite Modification Date: 2026-02-28 @ 10:38 PM
Study NCT ID: NCT00580333
Status: COMPLETED
Last Update Posted: 2021-05-26
First Post: 2007-12-20
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None PR negative View
None ER negative View
None HER2 negative View